Table 1

Percent of control gamma2 L/S ratio of the drug treatments

TreatmentPercent of control gamma-2L/S ratioS.E.M.TreatmentPercent of control gamma-2L/S ratioS.E.M.
Time course I%GABAAreceptor agonist treatments%
 1-Day PB52.51-a 3  PB 500 μM38.81-a  2
 2-Day PB41.0a,d 3.3 Ethanol 100 mM101.2 3.3
 3-Day PB38.7a,c 3.8 (+) HX 500 μM82.21-a  2.4
Time course II (−) HX 500 μM69.61-a  2.4
 1-Day PB91.55  Allopregnanolone1-f 1 μM100.7 3
 2-Day PB60.5a,c 4.6 Allopregnanolone1-f2 μM95.51-b  1.4
 3-Day PB38.61-a , 1-c , 1-e 2
Time course IIIGABAA receptor blockade for 3 days
 1-Day PB46.51-a 2.8 PX 10 μM95.1 2.2
 2-Day PB38.91-a 1.9 PX 10 μM and PB 500 μM20.2a,c  2.7
 3-Day PB28.4a,c,e 1.4 PB 500 μM23.3a,c  2.2
PB dose-response GABAA receptor blockade for 1 day
 100 μM PB84.31-a 3.2 PX 10 μM102.918
 250 μM PB61.1a,c 2.4 PX 10 μM and PB 500 μM34.3a,d  4.5
 500 μM PB45.4a,c,e 2.8 PB 500 μM42.9a,d  2.4
  • 1-a P > .001 vs. control

  • 1-b P > .01 vs. control

  • 1-c P > .001 vs. day-1 or 100 μM PB.

  • 1-d P > .01 vs. day-1 or 100 μM PB.

  • 1-e P > .001 vs. day-2 or 250 μM PB.

  • 1-f Allopregnanolone = 5α-pregnane-3α-ol-20-one.